Covered recipient · General Payments record
BRITTANY EA HAGER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,353.49
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.27 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $114.66 | 6 |
| ABBVIE INC. | $50.91 | 2 |
| Sumitomo Pharma America, Inc. | $45.92 | 2 |
| Axonics Modulation Technologies, Inc. | $33.80 | 1 |
| Dendreon Pharmaceuticals LLC | $25.14 | 1 |
| Janssen Biotech, Inc. | $21.94 | 1 |
| ACCORD HEALTHCARE, INC. | $21.34 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.41 | 1 |
| Endo Pharmaceuticals Inc. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.31 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107271609 | CMS |
| ABBVIE INC. | $23.60 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107271611 | CMS |
| ACCORD HEALTHCARE, INC. | $21.34 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120080078 | CMS |
| Axonics, Inc. | $33.80 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142380274 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.41 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086348577 | CMS |
| Dendreon Pharmaceuticals LLC | $25.14 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149328876 | CMS |
| Endo Pharmaceuticals Inc. | $16.15 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137019832 | CMS |
| Janssen Biotech, Inc. | $21.94 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078843285 | CMS |
| PFIZER INC. | $16.57 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624890 | CMS |
| PFIZER INC. | $22.26 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624523 | CMS |
| PFIZER INC. | $20.69 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624527 | CMS |
| PFIZER INC. | $16.91 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624883 | CMS |
| PFIZER INC. | $19.86 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624886 | CMS |
| PFIZER INC. | $18.37 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131622938 | CMS |
| Sumitomo Pharma America, Inc. | $16.27 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148964862 | CMS |
| Sumitomo Pharma America, Inc. | $29.65 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148964864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.